vimarsana.com

Latest Breaking News On - Yair lotan - Page 1 : vimarsana.com

UTSW Research: Improved bladder cancer detection,

UTSW Research: Improved bladder cancer detection,
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.

New Real-World Retrospective Analysis Presented at AUA 2024 Reports 86% Recurrence-Free Survival (RFS) at 24 Months with JELMYTO® Across All Studied Patient and Disease Characteristics in Cohort of Responders to Induction Therapy

Valar Labs Announces Validation of First Histology-based Test to Predict Response to BCG in Bladder Cancer – IT Business Net

Valar Labs Announces Validation of First Histology-based Test to Predict Response to BCG in Bladder Cancer – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Phase 4 study evaluating real-world use of ADSTILADRIN® (nadofaragene filadenovec-vncg)

Phase 4 study evaluating real-world use of ADSTILADRIN® (nadofaragene filadenovec-vncg)
independantexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from independantexpress.com Daily Mail and Mail on Sunday newspapers.

Outcomes of Bladder-Sparing Therapy for BCG-Unresponsive NMIBC Worsen Over Time

“Patients need to be monitored closely with a low threshold for rebiopsy to detect recurrences as early as possible so that other treatments can be offered,” said investigator Yair Lotan, MD. A study determined the oncologic risks of bladder-sparing therapy over time in BCG-unresponsive bladder cancer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.